← Leaderboards
Philip Raskin
University Of Texas Sw Med Ctr/Dallas
$7,947,079
Attributed
$7,947,079
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $669.2K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$7,947,079 · 10
By mechanism
U01$5,258,586 · 2
M01$2,688,493 · 8
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Madhukar H Trivedi$36,286,053
- Khashayar Sakhaee$14,492,169
- Lidia S Szczepaniak$2,417,780
- Connie C. W. Hsia$14,479,259
- Robert Joseph Gatchel$9,390,119
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchInsulinClinical TrialsDiabetes Mellitus TherapyInsulin Dependent Diabetes MellitusHuman Therapy EvaluationDiabetes MellitusImmunoregulationBlood GlucoseBiomarkerDisease /Disorder Prevention /ControlBlindnessImmuneAffectDisease /Disorder Proneness /RiskAdverse EffectsCost SavingsHealth Care CostsCell PhysiologyBeta CellBaseDiet Route /ScheduleAmputation
Grant awards (30)
Type 1 Diabetes TrialNet: Clinical Centers (U01)$547,799
U01 · FY2013 · DK · contact PI
Type 1 Diabetes TrialNet: Clinical Centers (U01)$492,144
U01 · FY2012 · DK · contact PI
Type 1 Diabetes TrialNet: Clinical Centers (U01)$625,154
U01 · FY2011 · DK · contact PI
Type 1 Diabetes TrialNet: Clinical Centers (U01)$662,001
U01 · FY2010 · DK · contact PI
Type 1 Diabetes TrialNet: Clinical Centers (U01)$635,181
U01 · FY2009 · DK · contact PI
Diabetes Type 1 TrialNet: Clinical Centers$669,217
U01 · FY2007 · DK · contact PI
NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$591
M01 · FY2006 · RR · contact PI
TO COMPARE THE RELIABILITY OF MMTT AND IV GLUCAGON STIMULATION TEST$295
M01 · FY2006 · RR · contact PI
DPT-1 TrialNet: Clinical Centers$1
U01 · FY2006 · DK · contact PI
DPT-1 TrialNet: Clinical Centers$365,138
U01 · FY2005 · DK
PROLONGED HYPERGLYCEMIA EFFECTS ON INSULIN SECRETION IN DIABETES$10,617
M01 · FY2005 · RR
DPT-1 TrialNet: Clinical Centers$319,196
U01 · FY2004 · DK
Pathophysiology of Ketosis-Prone Diabetes in Obese Adults$16,832
M01 · FY2004 · RR
Prolonged hyperglycemia effects on insulin secretion in diabetes$16,168
M01 · FY2004 · RR
Diabetes Prevention Trial - Type I Diabetes (DPT-1)$3,322
M01 · FY2004 · RR
DPT-1 TrialNet: Clinical Centers$311,047
U01 · FY2003 · DK
DPT-1 TrialNet: Clinical Centers$322,419
U01 · FY2002 · DK
GLUCAGON SECRETION IN WELL CONTROLLED DIABETES MELLITUS$321,374
M01 · FY2002 · RR
CLINICAL EVALUATION OF GLUCOSE MICROELECTRODES$321,374
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT 1)$321,374
M01 · FY2002 · RR
ACUTE GLUCOSE DISPOSAL POST INTRAVENOUS GLUCOSE LOAD$321,374
M01 · FY2002 · RR
ACUTE GLUCOSE DISPOSAL POST INTRAVENOUS GLUCOSE LOAD$321,374
M01 · FY2001 · RR
GLUCAGON SECRETION IN WELL CONTROLLED DIABETES MELLITUS$321,374
M01 · FY2001 · RR
CLINICAL EVALUATION OF GLUCOSE MICROELECTRODES$321,374
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT 1)$321,374
M01 · FY2001 · RR
Diabetes type 1 TrialNet: Clinical Centers$309,289
U01 · FY2001 · DK
ACUTE GLUCOSE DISPOSAL POST INTRAVENOUS GLUCOSE LOAD$34,838
M01 · FY2000 · RR
CLINICAL EVALUATION OF GLUCOSE MICROELECTRODES$34,838
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT 1)$0
M01 · FY2000 · RR
GLUCAGON SECRETION IN WELL CONTROLLED DIABETES MELLITUS$0
M01 · FY2000 · RR